Log in to save to my catalogue

Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognosti...

Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognosti...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4448393

Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non‐small cell lung cancer patients

About this item

Full title

Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non‐small cell lung cancer patients

Publisher

Singapore: John Wiley & Sons, Inc

Journal title

Thoracic cancer, 2015-05, Vol.6 (3), p.275-287

Language

English

Formats

Publication information

Publisher

Singapore: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
The neutrophil to lymphocyte ratio (NLR) was recently shown to be a remarkable prognostic factor in tumors. Moreover, some studies have indicated that the combination of NLR and platelet to lymphocyte ratio (PLR) could be a better prognostic factor. As the combined prognostic value of NLR and PLR in non‐small cell lung cancer (NSCLC)...

Alternative Titles

Full title

Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non‐small cell lung cancer patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4448393

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4448393

Other Identifiers

ISSN

1759-7706

E-ISSN

1759-7714

DOI

10.1111/1759-7714.12178

How to access this item